Clinical Trials for Precigen

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Precigen

Clinical Trials (5)

PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer

PHASE2Recruiting

46 participants

Started: Mar 21, 2025 · Completed: Jan 30, 2028

5 conditions2 sponsors3 locations

Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies

PHASE1Active, not recruiting

Started: Jan 25, 2023 · Completed: Mar 31, 2026

5 conditions2 sponsors1 location

Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis

PHASE1/PHASE2Active, not recruiting

38 participants

Started: Mar 16, 2021 · Completed: Jun 5, 2026

3 conditions2 sponsors1 location

PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS

PHASE1Active, not recruiting

88 participants

Started: May 20, 2019 · Completed: Aug 1, 2025

2 conditions1 sponsor2 locations

Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer

PHASE1Active, not recruiting

71 participants

Started: Apr 30, 2019 · Completed: Nov 15, 2028

34 conditions1 sponsor2 locations